Description

Global Cytomegalovirus Diagnostics Market

 

Cytomegalovirus (CMV) infection is the common herpes virus infection having different symptoms which occurs in all ages of people around the world. Cytomegalovirus (CMV) infection is a communicable and easily prone through the body fluids like urine, saliva, blood, breast milk and semen. The infection may spread fast from urine or saliva from people who are infected with CMV having virus in their bodily fluids. The disease can transmit from pregnant to baby during delivery. Organ transplant and blood transfusion are the other way for the transmission for the disease.

 

Cytomegalovirus diagnostics market is mainly propelling by the rise in the prevalence of CMV infections, growing awareness about herpes disease, initiatives taken by key market players for the diagnosis of CMV infection are propelling the growth of CMV diagnostics market. Moreover, rise in the support of government, and development of healthcare infrastructure are anticipated to propel growth of CMV diagnostics market. Lack of awareness and price sensitivity are the few factors hampering the growth of CMV diagnostics market.

 

The global cytomegalovirus Diagnostics market is classified on the basis of test, application, end-user, and geography.

 

Based on test, the global cytomegalovirus Diagnostics market is segmented into the following:

  • Serology
  • Cell culture
  • Antigenemia assay
  • Polymerase Chain Reaction Amplification
  • Immunohistochemistry
  • Nucleic acid sequence-based amplification (NASBA)
  • Hybrid capture assay

 

Based on application, the global cytomegalovirus diagnostics market is segmented into the following

  • Retinitis
  • Pneumonia
  • Gastrointestinal Ulcers
  • Encephalitis
  • Others (Mouth Ulcers, Pharyngitis, etc.)

 

Based on the end-user, the global cytomegalovirus diagnostics market is segmented into the following:

  • Hospitals
  • Diagnostic Centers
  • Others

 

Rise in diagnosis of CMV cases propelling the growth of global cytomegalovirus diagnosis market. According to Public Health Agency of Canada, 40%-100% of global population are having CMV antibody in the body. Patients with HIV and who has undergone organ transplantation, new-borns, and premature infants are having high risk of CMV infection. As per Centres for Disease Control and Prevention 1 per 150 infants are born with CMV infection in U.S. but only 1 in 5 infants are infected with CMV are having long term health issues.

 

Geographically cytomegalovirus diagnostics market is segmented as Latin America, North America, Asia- Pacific, Europe and The Middle East & Africa. Growing awareness about the herpes virus and rise in diagnosis of CMV cases in the developed regions such as Europe and North America are dominating the market. Initiatives taken by government about the awareness of the CMV disease, rise in healthcare expenditure and increase in disposable income are the few factors propelling market growth in Asia-Pacific region.

 

  • In Jun 2017, Abbott received U.S. FDA approval for Real-time CMV molecular test, the only cytomegalovirus test which is available commercially which amplifies two selective regions of CMV genome

 

  • In May 2016, Roche received U.S. FDA approval for its cytomegalovirus (CMV) test used in recipients of hematopoietic stem cells transplantation

 

Report Outline:

 

  • The report provides granular level information about the market size, regional market share and forecast from 2017-2023
  • The report covers in-detail insights about the competitor’s overview, key findings and their key strategies
  • The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
  • The report tracks recent innovations, key developments and startup’s details that are working in the industry
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario


Location

GEOGRAPHY

PBI Location Map

1. Executive Summary
2. Global Cytomegalovirus Diagnostics Market Introduction
2.1. Global Cytomegalovirus Diagnostics Market – Taxonomy
2.2. Global Cytomegalovirus Diagnostics Market –Definitions
2.2.1. Test Type
2.2.2. End User
3. Global Cytomegalovirus Diagnostics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Cytomegalovirus Diagnostics Market Dynamic Factors – Impact Analysis
4. Global Cytomegalovirus Diagnostics Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Cytomegalovirus Diagnostics Market, By Test Type, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.1. Serology
5.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Cell Culture
5.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Antigenemia Assay
5.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Polymerase Chain Reaction Amplification
5.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Immunohistochemistry
5.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Nucleic Acid Sequence-based Amplification (NASBA)
5.6.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis
5.7. Hybrid Capture Assay
5.7.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.7.3. Market Opportunity Analysis
6. Global Cytomegalovirus Diagnostics Market, By Application, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.1. Retinitis
6.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Pneumonia
6.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Gastroenteritis
6.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Encephalitis
6.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Others (Mouth Ulcers, Pharyngitis, etc.)
6.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
7. Global Cytomegalovirus Diagnostics Market, By End User, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.1. Hospitals
7.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Diagnostic Centers
7.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Others
7.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. Global Cytomegalovirus Diagnostics Market Forecast, By Region, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
8.1. North America
8.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Cytomegalovirus Diagnostics Market – Opportunity Analysis Index, By Test Type, By Application, By End User, and Region, 2018 – 2024
9. North America Cytomegalovirus Diagnostics Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
9.1. Test Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Serology
9.1.2. Cell culture
9.1.3. Antigenemia assay
9.1.4. Polymerase Chain Reaction Amplification
9.1.5. Immunohistochemistry
9.1.6. Nucleic acid sequence-based amplification (NASBA)
9.1.7. Hybrid capture assay
9.2. Application Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.2.1. Retinitis
9.2.2. Pneumonia
9.2.3. Gastrointestinal Ulcers
9.2.4. Encephalitis
9.2.5. Others (Mouth Ulcers, Pharyngitis, etc.)
9.3. End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.3.1. Hospitals
9.3.2. Diagnostic Centers
9.3.3. Others
9.4. Country Analysis 2016 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. U.S.
9.4.2. Canada
9.5. North America Cytomegalovirus Diagnostics Market – Opportunity Analysis Index, By Test Type, By Application, By End User, and Country, 2018 – 2024
9.6. North America Cytomegalovirus Diagnostics Market Dynamics – Trends
10. Europe Cytomegalovirus Diagnostics Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
10.1. Test Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Serology
10.1.2. Cell culture
10.1.3. Antigenemia assay
10.1.4. Polymerase Chain Reaction Amplification
10.1.5. Immunohistochemistry
10.1.6. Nucleic acid sequence-based amplification (NASBA)
10.1.7. Hybrid capture assay
10.2. Application Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Retinitis
10.2.2. Pneumonia
10.2.3. Gastrointestinal Ulcers
10.2.4. Encephalitis
10.2.5. Others (Mouth Ulcers, Pharyngitis, etc.)
10.3. End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.3.1. Hospitals
10.3.2. Diagnostic Centers
10.3.3. Others
10.4. Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.4.1. Germany
10.4.2. UK
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Russia
10.4.7. Poland
10.4.8. Rest of Europe
10.5. Europe Cytomegalovirus Diagnostics Market – Opportunity Analysis Index, By Test Type, By Application, By End User, and Country, 2018 – 2024
10.6. Europe Cytomegalovirus Diagnostics Market Dynamics – Trends
11. Asia-Pacific Cytomegalovirus Diagnostics Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
11.1. Test Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Serology
11.1.2. Cell culture
11.1.3. Antigenemia assay
11.1.4. Polymerase Chain Reaction Amplification
11.1.5. Immunohistochemistry
11.1.6. Nucleic acid sequence-based amplification (NASBA)
11.1.7. Hybrid capture assay
11.2. Application Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Retinitis
11.2.2. Pneumonia
11.2.3. Gastrointestinal Ulcers
11.2.4. Encephalitis
11.2.5. Others (Mouth Ulcers, Pharyngitis, etc.)
11.3. End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.3.1. Hospitals
11.3.2. Diagnostic Centers
11.3.3. Others
11.4. Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. ASEAN
11.4.5. Australia & New Zealand
11.4.6. Rest of Asia-Pacific
11.5. Asia-Pacific Cytomegalovirus Diagnostics Market – Opportunity Analysis Index, By Test Type, By Application, By End User, and Country, 2018 – 2024
11.6. Asia-Pacific Cytomegalovirus Diagnostics Market Dynamics – Trends
12. Latin America Cytomegalovirus Diagnostics Market Analysis, 2012 – 2012 – 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
12.1. Test Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Serology
12.1.2. Cell culture
12.1.3. Antigenemia assay
12.1.4. Polymerase Chain Reaction Amplification
12.1.5. Immunohistochemistry
12.1.6. Nucleic acid sequence-based amplification (NASBA)
12.1.7. Hybrid capture assay
12.2. Application Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Retinitis
12.2.2. Pneumonia
12.2.3. Gastrointestinal Ulcers
12.2.4. Encephalitis
12.2.5. Others (Mouth Ulcers, Pharyngitis, etc.)
12.3. End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.3.1. Hospitals
12.3.2. Diagnostic Centers
12.3.3. Others
12.4. Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Argentina
12.4.4. Venezuela
12.4.5. Rest of Latin America
12.5. Latin America Cytomegalovirus Diagnostics Market – Opportunity Analysis Index, By Test Type, By Application, By End User, and Country, 2018 – 2024
12.6. Latin America Cytomegalovirus Diagnostics Market Dynamics – Trends
13. Middle East and Africa Cytomegalovirus Diagnostics Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
13.1. Test Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Serology
13.1.2. Cell culture
13.1.3. Antigenemia assay
13.1.4. Polymerase Chain Reaction Amplification
13.1.5. Immunohistochemistry
13.1.6. Nucleic acid sequence-based amplification (NASBA)
13.1.7. Hybrid capture assay
13.2. Application Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Retinitis
13.2.2. Pneumonia
13.2.3. Gastrointestinal Ulcers
13.2.4. Encephalitis
13.2.5. Others (Mouth Ulcers, Pharyngitis, etc.)
13.3. End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.3.1. Hospitals
13.3.2. Diagnostic Centers
13.3.3. Others
13.4. Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.4.1. Gulf Cooperation Council (GCC) Countries
13.4.2. Israel
13.4.3. South Africa
13.4.4. Rest of MEA
13.5. MEA Cytomegalovirus Diagnostics Market – Opportunity Analysis Index, By Test Type, By Application, By End User, and Country, 2018 – 2024
13.6. MEA Cytomegalovirus Diagnostics Market Dynamics – Trends
14. Competition Landscape
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Cell Medical Ltd. (U.K.)
14.2.2. Merck & Co. Inc. (U.S.)
14.2.3. Chimerix, Inc. (U.S.)
14.2.4. Abbott Laboratories (U.S.)
14.2.5. Affymetrix, Inc. (U.S.)
14.2.6. Becton, Dickinson and Company (U.S.)
14.2.7. Bio-Rad Laboratories, Inc. (U.S.)
14.2.8. F. Hoffmann-La Roche Ltd.( Switzerland)
14.2.9. Johnson and Johnson Services Inc.,(U.S.)
15. Research Methodology
16. Key Assumptions and Acronyms

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

 

 

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX